Funds and ETFs Shanghai Haohai Biological Technology Co., Ltd.

Equities

6826

CNE100001W69

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:22 2024-04-29 am EDT 5-day change 1st Jan Change
41.55 HKD +1.47% Intraday chart for Shanghai Haohai Biological Technology Co., Ltd. +9.34% +3.10%

ETFs positioned on Shanghai Haohai Biological Technology Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
2.24% 4 M€ -27.92%
0.01% 117 M€ +1.49% -
0.00% 7 M€ +1.95% -
0.00% 34 M€ +2.67% -
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
37.91 CNY
Average target price
65.08 CNY
Spread / Average Target
+71.68%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6826 Stock
  4. Funds and ETFs Shanghai Haohai Biological Technology Co., Ltd.